Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice.

Shanahan NA, Velez LP, Masten VL, Dulawa SC.

Biol Psychiatry. 2011 Dec 1;70(11):1039-48. doi: 10.1016/j.biopsych.2011.07.032. Epub 2011 Sep 13.

PMID:
21920503
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder.

El Mansari M, Blier P.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 May;30(3):362-73. Epub 2006 Jan 20. Review.

PMID:
16427729
[PubMed - indexed for MEDLINE]
3.

Neurobiology and clinical pharmacology of obsessive-compulsive disorder.

Micallef J, Blin O.

Clin Neuropharmacol. 2001 Jul-Aug;24(4):191-207. Review.

PMID:
11479390
[PubMed - indexed for MEDLINE]
4.

OCD: where the serotonin selectivity story begins.

Pigott TA.

J Clin Psychiatry. 1996;57 Suppl 6:11-20. Review.

PMID:
8647793
[PubMed - indexed for MEDLINE]
5.

Issues in the pharmacological treatment of obsessive-compulsive disorder.

Math SB, Janardhan Reddy YC.

Int J Clin Pract. 2007 Jul;61(7):1188-97. Epub 2007 May 18. Review.

PMID:
17511795
[PubMed - indexed for MEDLINE]
6.

[Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].

Nakamae T.

Seishin Shinkeigaku Zasshi. 2011;113(10):1016-25. Review. Japanese.

PMID:
22187889
[PubMed - indexed for MEDLINE]
7.

Pharmacologic therapy of obsessive compulsive disorder.

DeVeaugh-Geiss J.

Adv Pharmacol. 1994;30:35-52. Review.

PMID:
7833296
[PubMed - indexed for MEDLINE]
8.

Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.

Dell'Osso B, Nestadt G, Allen A, Hollander E.

J Clin Psychiatry. 2006 Apr;67(4):600-10. Review.

PMID:
16669725
[PubMed - indexed for MEDLINE]
9.

Different roles for serotonin in anti-obsessional drug action and the pathophysiology of obsessive-compulsive disorder.

Delgado PL, Moreno FA.

Br J Psychiatry Suppl. 1998;(35):21-5. Review.

PMID:
9829023
[PubMed - indexed for MEDLINE]
10.

A qualitative analysis of nonresponse: management of treatment-refractory obsessive-compulsive disorder.

Pallanti S, Hollander E, Goodman WK.

J Clin Psychiatry. 2004;65 Suppl 14:6-10. Review.

PMID:
15554782
[PubMed - indexed for MEDLINE]
11.

The pharmacotherapy of obsessive-compulsive disorder.

McDougle CJ, Goodman WK, Price LH.

Pharmacopsychiatry. 1993 May;26 Suppl 1:24-9. Review.

PMID:
8378419
[PubMed - indexed for MEDLINE]
12.

Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.

Goodman WK, Ward H, Kablinger A, Murphy T.

J Clin Psychiatry. 1997;58 Suppl 5:32-49. Review.

PMID:
9184625
[PubMed - indexed for MEDLINE]
13.

Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.

Korff S, Harvey BH.

Psychiatr Clin North Am. 2006 Jun;29(2):371-90. Review.

PMID:
16650714
[PubMed - indexed for MEDLINE]
14.

Metabolic and toxicological considerations for obsessive-compulsive disorder drug therapy.

Sayyah M, Majzoob S, Sayyah M.

Expert Opin Drug Metab Toxicol. 2013 Jun;9(6):657-73. doi: 10.1517/17425255.2013.783011. Epub 2013 Mar 25. Review.

PMID:
23521155
[PubMed - indexed for MEDLINE]
15.

[Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].

Etain B, Bonnet-Perrin E.

Encephale. 2001 May-Jun;27(3):280-9. Review. French.

PMID:
11488259
[PubMed - indexed for MEDLINE]
16.

Role of dopamine systems in obsessive-compulsive disorder (OCD): implications from a novel psychostimulant-induced animal model.

Szechtman H, Culver K, Eilam D.

Pol J Pharmacol. 1999 Jan-Feb;51(1):55-61. Review.

PMID:
10389145
[PubMed - indexed for MEDLINE]
17.

SSRIs in the treatment of obsessive-compulsive disorder.

Cartwright C, Hollander E.

Depress Anxiety. 1998;8 Suppl 1:105-13. Review.

PMID:
9809222
[PubMed - indexed for MEDLINE]
18.

Beyond depression: citalopram for obsessive-compulsive disorder.

Pato MT.

Int Clin Psychopharmacol. 1999 May;14 Suppl 2:S19-26. Review.

PMID:
10471169
[PubMed - indexed for MEDLINE]
19.

Pharmacotherapy of obsessive compulsive disorder.

Goodman WK, McDougle CJ, Price LH.

J Clin Psychiatry. 1992 Apr;53 Suppl:29-37. Review.

PMID:
1532962
[PubMed - indexed for MEDLINE]
20.

Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.

Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR.

Br J Psychiatry Suppl. 1989 Dec;(8):15-24. Review.

PMID:
2692636
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk